As of April 23, 2025, Independence Blue Cross (IBX) and Independence Administrators have expanded the Direct Ship Drug Program to include more than 100 injectable and infusion drugs eligible for coverage under the medical benefit.
In-network providers can order any drug on this program at no cost.
Newly added drugs
The following drugs will be added to the program:
- Byooviz™
- Erzofri®
- Ocrevus Zunovo®
- Risvan®
- Tremfya®
- Yesintek™
Important reminder
All drugs in the Direct Ship Drug Program require precertification review, even if they are not listed on the published precertification list.
Learn more
For the updated drug list, visit our Direct Ship Drug Program webpages:
25-0070